The latest announcement is out from Healios KK ( (JP:4593) ).
Healios K.K. has announced a proposal to reduce its capital stock and capital reserves, aiming to eliminate carry-forward losses and reduce tax burdens. The proposal involves transferring the reduced amounts to other capital surplus and then to retained earnings, without affecting the number of outstanding shares or net asset value per share.
More about Healios KK
Healios K.K. operates in the biotechnology industry, primarily focusing on the development and commercialization of regenerative medicine therapies.
YTD Price Performance: 111.30%
Average Trading Volume: 2,883,535
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen37.96B
For an in-depth examination of 4593 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com